Ann: Company Overview and Strategic Update, page-9

one thing that is overlooked by the larger market is that while the USA is still at the research stage with their mdma products (phase 3s) - they are still stuck in the research phase

EMD has passed this stage to be "one of the only companies globally to be delivering the service to real customers outside of research" - the USA can't do that until they have an approved product, which is still many years away. We are also the only company that can provide the holistic support that these mental services need.

with Pax and the emyria clinics we now have quite a good revenue boost.

Future looking
I could see that when the USA finally approves a product they will still then be at day one of 'ok how do we deliver this service' - they would be excited to partner with EMD having likely years of experience delivering the service and holistic wrap-around services that are required.